Ying-xia Liu

Shenzhen, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Meplazumab, a CD147 antibody, for severe COVID-19: a double-blind, randomized, placebo-controlled, phase 3 clinical trial.

Meplazumab, a CD147 antibody, for severe COVID-19: a double-blind, randomized, placebo-controlled, phase 3 clinical trial.

Journal: Signal transduction and targeted therapy

Published: November 01, 2024

Factors associated with persistent positive in HBV DNA level in patients with chronic Hepatitis B receiving entecavir treatment.

Factors associated with persistent positive in HBV DNA level in patients with chronic Hepatitis B receiving entecavir treatment.

Journal: Frontiers in cellular and infection microbiology

Published: January 26, 2023

An-Luo-Hua-Xian Pill Improves the Regression of Liver Fibrosis in Chronic Hepatitis B Patients Treated with Entecavir.

An-Luo-Hua-Xian Pill Improves the Regression of Liver Fibrosis in Chronic Hepatitis B Patients Treated with Entecavir.

Journal: Journal of clinical and translational hepatology

Published: February 19, 2022

The relationship between SARS-COV-2 RNA positive duration and the risk of recurrent positive.

The relationship between SARS-COV-2 RNA positive duration and the risk of recurrent positive.

Journal: Infectious diseases of poverty

Published: January 13, 2021

Clinical diagnosis of severe COVID-19: A derivation and validation of a prediction rule.

Clinical diagnosis of severe COVID-19: A derivation and validation of a prediction rule.

Journal: World journal of clinical cases

Published: November 28, 2020

Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells.

Robust neutralization assay based on SARS-CoV-2 S-protein-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressing BHK21 cells.

Journal: Emerging microbes & infections

Published: September 07, 2020

Virus load and virus shedding of SARS-CoV-2 and their impact on patient outcomes.

Virus load and virus shedding of SARS-CoV-2 and their impact on patient outcomes.

Journal: World journal of clinical cases

Published: August 31, 2020

Implication of inhaled nitric oxide for the treatment of critically ill COVID-19 patients with pulmonary hypertension.

Implication of inhaled nitric oxide for the treatment of critically ill COVID-19 patients with pulmonary hypertension.

Journal: ESC heart failure

Published: June 21, 2020

First case of COVID-19 complicated with fulminant myocarditis: a case report and insights.

First case of COVID-19 complicated with fulminant myocarditis: a case report and insights.

Journal: Infection

Published: February 06, 2020

Unsatisfying antiviral therapeutic effect in patients with mother-to-child transmissed chronic hepatitis B virus infection: a prospective multi-center clinical study.

Unsatisfying antiviral therapeutic effect in patients with mother-to-child transmissed chronic hepatitis B virus infection: a prospective multi-center clinical study.

Journal: Chinese medical journal

Published: November 15, 2019

CSH guidelines for the diagnosis and treatment of drug-induced liver injury.

CSH guidelines for the diagnosis and treatment of drug-induced liver injury.

Journal: Hepatology international

Published: September 20, 2016

Combined acoustic radiation force impulse, aminotransferase to platelet ratio index and Forns index assessment for hepatic fibrosis grading in hepatitis B.

Combined acoustic radiation force impulse, aminotransferase to platelet ratio index and Forns index assessment for hepatic fibrosis grading in hepatitis B.

Journal: World journal of hepatology

Published: January 08, 2016

Showing 1-12 of 18

Last Updated: 09/26/2026